The availability of PrEP is drawing in high-risk individuals who did not previously attend sexual health services

Integrase inhibitors may be safe in pregnancy, but more data are needed.

Trend poses threat of congenital syphilis, signals need for screening.

No isolates with resistance to ceftriaxone were detected in 2017 or in 2016, in contrast to one in 2015, five in 2014 and seven in 2013.

Single allo-HSCT with homozygous CCR5Δ32 donor cells may be sufficient to achieve HIV-1 remission without irradiation.

High tolerability reinforces utility.

Patients had received a median 14 years of ART.

New triple therapy based on the integrase inhibitor bictegravir would be available in England under new proposal.

Without drastic changes, administration's 90% reduction goal by 2030 unlikely to be realized.

Rate of HIV-infected people receiving care would need to jump to 95% within 6 years.

New standard includes condom distributions schemes, access to appointments within 2 days, and repeat testing every 3 months for men who have sex with men

Research presented at Cancer Research UK’s Early Diagnosis Conference.

Ignore variable assays and opt for frequent reassessment and monitoring.

Rapid worldwide scale-up could virtually eliminate the disease by century's end.